标题
New and emerging treatments for Alzheimer's disease
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 17, Issue 2, Pages 147-156
出版商
Informa Healthcare
发表日期
2012-03-24
DOI
10.1517/14728214.2012.675327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials
- (2017) Donna M. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
- (2017) Yazhou Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Lithium Treatment Arrests the Development of Neurofibrillary Tangles in Mutant Tau Transgenic Mice with Advanced Neurofibrillary Pathology
- (2017) Karelle Leroy et al. JOURNAL OF ALZHEIMERS DISEASE
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease
- (2011) Clive Ballard et al. Expert Review of Neurotherapeutics
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Exercise training increases size of hippocampus and improves memory
- (2011) K. I. Erickson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Goal-Oriented Cognitive Rehabilitation for People With Early-Stage Alzheimer Disease: A Single-Blind Randomized Controlled Trial of Clinical Efficacy
- (2010) Linda Clare et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Effects of Aerobic Exercise on Mild Cognitive Impairment
- (2010) Laura D. Baker et al. ARCHIVES OF NEUROLOGY
- Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
- (2010) G. Maher-Edwards et al. Current Alzheimer Research
- Putting brain training to the test
- (2010) Adrian M. Owen et al. NATURE
- Dimebon disappointment
- (2010) Roy W Jones Alzheimers Research & Therapy
- Results of the first-in-man study with the active Aβ Immunotherapy CAD106 in Alzheimer patients
- (2009) Bengt G. Winblad et al. Alzheimers & Dementia
- Clinical trials of EHT 0202, a neuroprotective and procognitive alpha-secretase stimulator for Alzheimer's disease
- (2009) Laurent Desire et al. Alzheimers & Dementia
- Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease
- (2009) Michael Gold et al. Alzheimers & Dementia
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
- (2009) Joanne Rodda et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
- (2009) Kamila B. Kurakhmaeva et al. JOURNAL OF DRUG TARGETING
- Cognitive Training for Early-Stage Alzheimer’s Disease and Dementia
- (2009) Fang Yu et al. Journal of Gerontological Nursing
- Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease
- (2009) Katy A. Chalmers et al. JOURNAL OF NEUROLOGY
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
- (2009) M. Blurton-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
- (2008) Eric R. Siemers et al. Alzheimers & Dementia
- Emerging and potential therapies for Alzheimer's disease
- (2008) Heledd H Griffiths et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Reassessing the amyloid cascade hypothesis of Alzheimer's disease
- (2008) Sanjay W. Pimplikar INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A feasibility and tolerability study of lithium in Alzheimer's disease
- (2008) Alastair Macdonald et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease
- (2008) Nicola T. Lautenschlager et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
- (2008) K A Bates et al. MOLECULAR PSYCHIATRY
- Hope in Alzheimer's fight emerges from unexpected places
- (2008) Trisha Gura NATURE MEDICINE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started